1)OPEC cut its forecast for global oil demand growth in 2024 citing softer expectations for China, a reduction that highlights the dilemma faced by the wider OPEC+ group in raising production from October. This is the first cut in OPEC’s 2024 forecast since it was made in July...
Also, the significant market percentage for epilepsy drugs may be in North America. This is because of a boom in neurological problems like Parkinson's ailment, along with multiplied focus and tremendous research outcomes. The US invests in growing new epilepsy drugs, enhancing the general marketpl...
The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029). Biguanides are a class of medications used to treat type 2 diabetes. They work by reducing the pr...
forecast|sweden-cosmetics-products-market-industry|united-states-organic-skin-care-market|chile-hair-care-market-industry|hair-color-spray-market|europe-bath-shower-products-market|bath-shower-products-market|australia-beauty-and-personal-care-products-market-industry|europe-hair-styling-products-market|...
.neo_lp_price,.neo_lp_price span,.neo_lp_discount,ul.neo_lp_list,ul.neo_lp_list li,a.neo_download_sample,.neo_border,.neo_heading,.neo_discount_Wrapper")}}, R_708874_717_1_2_1:{ fn:function(log,nonce=''){return (function(x) { if(!vwo_$.fn.vwoRevertHtml){ return; }; ...
The Gastroesophageal Reflux Disease Market is growing at a CAGR of 4.3% over the next 5 years. Pfizer, Inc., Johnson & Johnson, SRS Life Sciences, Takeda Pharmaceutical Co., Ltd., Haleon Group of Companies are the major companies operating in Gastroesoph